Identify and treat specific local pain generators, if present
Cutaneous stimulators (e.g., transcutaneous electrical nerve stimulation)
Local treatment (e.g., physical therapy, manipulation, massage, heat)
Minor interventions (e.g., anesthetic or steroid joint injection)
Surgery
Topical anesthetics (e.g., lidocaine ointment or patches)
Promote healthy behaviors
Physical activity
Weight control
Restore sleep
Depending on coexisting problems, useful agents may include trazodone, tricyclic antidepressants, gabapentin (Neurontin), pregabalin (Lyrica), mirtazapine (Remeron), melatonin, or quetiapine (Seroquel); use of benzodiazepines or their analogs should be avoided because of tolerance and abuse potential
Start adjuvant pain medications (listed in order of recommended treatments)
Tricyclic antidepressants are indicated for neuropathic pain; nortriptyline (Pamelor), desipramine (Norpramin), amitriptyline, and doxepin are also useful for localized or generalized pain with coexisting headache, depression, panic disorder, or tobacco addiction
Serotonin-norepinephrine reuptake inhibitors are indicated for neuropathic pain; duloxetine (Cymbalta) and milnacipran (Savella) are most effective for localized or generalized pain with depression or anxiety, venlafaxine (Effexor) less so; doses for treatment of pain tend to be higher than those for depression
Pregabalin is approved by the U.S. Food and Drug Administration for neuropathic pain and fibromyalgia; gabapentin has similar effectiveness, is available generically, and is more widely used, but it is sedating, and dosing is complex; may be synergistic when combined with tricyclic antidepressants
Anticonvulsants; carbamazepine (Tegretol) is a first-line agent for trigeminal neuralgia, but third-line (with oxcarbazepine [Trileptal] and lamotrigine [Lamictal]) for other neuropathic pain
Migraine chemoprophylaxis (e.g., beta blockers, calcium channel blockers, tricyclic antidepressants, topiramate [Topamax])
Treat comorbid psychiatric illness
Use of pharmacologic and psychotherapeutic measures is essential for improvement of symptoms and function
Commonly associated disorders include anxiety, depression, posttraumatic stress disorder in persons who have experienced physical, sexual, or emotional trauma; treatment should include psychotherapy, biofeedback, mindfulness training, posttraumatic stress disorder therapy, relationship counseling, social and financial counseling, and substance abuse counseling
Trial of opioid therapy (initiation or continuation)
Patients should have no contraindications for opioid therapy
Patients with diffuse, centralized pain or headache are less likely to benefit from opioid therapy and may be harmed by opioid toxicities
Select patients with specific somatic, peripheral, or neuropathic pain may benefit from low-dose opioid therapy in combination with other treatments
Treatment should produce demonstrable functional improvement, not merely a reduction in pain scores, or opioids should be tapered or discontinued